SnakeAI is a MedTech startup revolutionizing colorectal cancer screening with its AI-powered robotic colonoscopy system. Founded by Jiawei Xu, SnakeAI addresses critical challenges in healthcare by making screenings smarter, faster, and more patient friendly.

Colorectal cancer is the third most common cancer worldwide, yet millions of cases go undetected until late stages due to inefficiencies in traditional colonoscopy methods. These procedures are invasive, time-consuming, and costly, creating barriers for patients and healthcare providers alike.

SnakeAI’s innovative solution integrates advanced AI diagnostics, autonomous robotic movement, and a single-use disposable design to enhance accuracy, reduce procedure times, and improve patient comfort. Currently in the proof-of-concept and R&D stages, SnakeAI is collaborating with healthcare providers to refine its system for clinical and regulatory readiness.

Simplifies the procedure for endoscopists, speeding up the screening process.

Compatible with any computing device, making it accessible to more healthcare facilities.

Eliminates the need for anesthesia or sedation, providing a pain-free procedure.

Enhances diagnostic accuracy with AI technology, reducing misdiagnoses of CRC.

Snake AI redefines colonoscopy with its state-of-the-art, AI-assisted device, delivering faster, smoother, and more comfortable screenings. Our innovative technology enhances accessibility and accuracy, reducing recovery time and eliminating the need for anesthesia, making proactive colon health easier and more efficient for both patients and healthcare providers.

Snake AI is at the forefront of medical innovation with our patented AI-assisted colonoscope technology. Our cutting-edge design features advanced airflow techniques for smoother navigation through the colon and AI capabilities that enhance diagnostic accuracy, setting a new standard in colonoscopy procedures.

At Snake AI, our mission is to revolutionize colonoscopy by leveraging advanced AI technology to enhance the efficiency, accuracy, and comfort of colon health screenings. We are committed to making proactive colon health more accessible and reliable for patients and healthcare providers worldwide. By continuously innovating and refining our patented technology, we strive to set new standards in medical diagnostics, ultimately improving patient outcomes and quality of care.